• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

地理因素不应成为尿路上皮癌的“肿瘤宿命”:消除局部、区域和国际障碍以改善医疗服务可及性。

Geography Should Not Be an "Oncologic Destiny" for Urothelial Cancer: Improving Access to Care by Removing Local, Regional, and International Barriers.

机构信息

Division of Hematology-Oncology, Department of Medicine, Penn State Cancer Institute, Hershey, PA.

Department of Urology, University of Virginia, Charlottesville, VA.

出版信息

Am Soc Clin Oncol Educ Book. 2022 Apr;42:1-14. doi: 10.1200/EDBK_350478.

DOI:10.1200/EDBK_350478
PMID:35471833
Abstract

Urothelial cancer care is particularly susceptible to geographical health disparity given its complex nature, requiring access to several specialists such as a urologist, a medical oncologist, a radiation oncologist, a surgical oncologist, and multidisciplinary care teams. Furthermore, other barriers to care access in underserved areas include travel burden, longer wait times, late-stage disease at the time of diagnosis, cost, type of treatment, less enrollment in clinical trials, lack of follow-up among cancer survivors, and less research funding in this area. Here, we discuss the impact of geographical location on access to urothelial cancer care, management decisions, and outcomes and we reflect on how to address geographical disparities in care delivery.

摘要

由于膀胱癌的复杂性,其治疗特别容易受到地域健康差异的影响,需要获得多位专家的治疗,如泌尿科医生、肿瘤内科医生、放射肿瘤学家、外科肿瘤学家和多学科护理团队。此外,服务不足地区获得护理的其他障碍包括旅行负担、更长的等待时间、诊断时的晚期疾病、成本、治疗类型、临床试验参与率较低、癌症幸存者缺乏随访以及该领域的研究资金较少。在这里,我们讨论了地理位置对膀胱癌治疗的可及性、管理决策和结果的影响,并反思了如何解决护理提供方面的地域差异。

相似文献

1
Geography Should Not Be an "Oncologic Destiny" for Urothelial Cancer: Improving Access to Care by Removing Local, Regional, and International Barriers.地理因素不应成为尿路上皮癌的“肿瘤宿命”:消除局部、区域和国际障碍以改善医疗服务可及性。
Am Soc Clin Oncol Educ Book. 2022 Apr;42:1-14. doi: 10.1200/EDBK_350478.
2
Exploring implications of Medicaid participation and wait times for colorectal screening on early detection efforts in Connecticut--a secret-shopper survey.探索医疗补助计划参与情况及结直肠癌筛查等待时间对康涅狄格州早期检测工作的影响——一项暗访调查
Conn Med. 2013 Apr;77(4):197-203.
3
Geographic disparities in residential proximity to colorectal and cervical cancer care providers.地理上与结直肠癌和宫颈癌医疗服务提供者的住所之间的距离存在差异。
Cancer. 2020 Mar 1;126(5):1068-1076. doi: 10.1002/cncr.32594. Epub 2019 Nov 8.
4
Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.超越黑木树:影响澳大利亚地区、农村和偏远地区的健康研究问题的快速综述。
Med J Aust. 2020 Dec;213 Suppl 11:S3-S32.e1. doi: 10.5694/mja2.50881.
5
Geographical disparities in access to cancer management and treatment services in England.英格兰癌症管理与治疗服务可及性方面的地理差异。
Health Place. 2016 Nov;42:11-18. doi: 10.1016/j.healthplace.2016.08.014. Epub 2016 Sep 8.
6
Medical oncology referral and systemic therapy of patients with advanced stage urothelial carcinoma.晚期尿路上皮癌患者的医学肿瘤转诊和系统治疗。
J Comp Eff Res. 2020 Sep;9(13):945-957. doi: 10.2217/cer-2020-0093. Epub 2020 Sep 23.
7
Geographic access to gynecologic cancer care in the United States.美国妇科癌症护理的地理可及性。
Gynecol Oncol. 2015 Jul;138(1):115-20. doi: 10.1016/j.ygyno.2015.04.025. Epub 2015 Apr 25.
8
Access to chemotherapy services by availability of local and visiting oncologists.根据当地和来访肿瘤学家的可用性获取化疗服务。
J Oncol Pract. 2014 Jan;10(1):26-31. doi: 10.1200/JOP.2013.001217.
9
Access to cancer services for rural colorectal cancer patients.农村结直肠癌患者获得癌症服务的情况。
J Rural Health. 2008 Fall;24(4):390-9. doi: 10.1111/j.1748-0361.2008.00186.x.
10
Association Between Geographic Access to Cancer Care, Insurance, and Receipt of Chemotherapy: Geographic Distribution of Oncologists and Travel Distance.获得癌症治疗的地理便利性、保险与化疗接受情况之间的关联:肿瘤学家的地理分布与出行距离
J Clin Oncol. 2015 Oct 1;33(28):3177-85. doi: 10.1200/JCO.2015.61.1558. Epub 2015 Aug 24.

引用本文的文献

1
Split-Dose Cisplatin Use, Eligibility Criteria, and Drivers for Treatment Choice in Patients with Locally Advanced or Metastatic Urothelial Carcinoma: Results of a Large International Physician Survey.局部晚期或转移性尿路上皮癌患者分剂量顺铂的使用、 eligibility标准及治疗选择的驱动因素:一项大型国际医生调查结果。 注:原文中“eligibility Criteria”中的“Criteria”拼写有误,正确拼写应为“Criteria”,翻译时保留了原文错误拼写。若纠正拼写错误后翻译为:局部晚期或转移性尿路上皮癌患者分剂量顺铂的使用、 eligibility标准及治疗选择的驱动因素:一项大型国际医生调查结果。 局部晚期或转移性尿路上皮癌患者分剂量顺铂的使用、 入选标准及治疗选择的驱动因素:一项大型国际医生调查结果。
Cancers (Basel). 2025 Feb 3;17(3):509. doi: 10.3390/cancers17030509.
2
Bladder image stitching algorithm for navigation and referencing using a standard cystoscope.标准膀胱镜导航和参考用膀胱图像拼接算法。
Sci Rep. 2024 Nov 25;14(1):29168. doi: 10.1038/s41598-024-80284-7.
3
Striving for Equity: Examining Health Disparities in Urologic Oncology.追求公平:审视泌尿肿瘤学中的健康差异。
Cancers (Basel). 2024 Oct 22;16(21):3559. doi: 10.3390/cancers16213559.
4
Access to Care and Healthcare Quality Metrics for Patients with Advanced Genitourinary Cancers in Urban versus Rural Areas.城市与农村地区晚期泌尿生殖系统癌症患者的医疗服务可及性和医疗质量指标
Cancers (Basel). 2023 Oct 27;15(21):5171. doi: 10.3390/cancers15215171.
5
Evaluating Oncologists' Practice Patterns and Decision-Making in Locally Advanced or Metastatic Urothelial Carcinoma: The US Physician PARADIGM Study.评估局部晚期或转移性尿路上皮癌肿瘤学家的实践模式和决策:美国医师 PARADIGM 研究。
Oncologist. 2024 Mar 4;29(3):244-253. doi: 10.1093/oncolo/oyad267.